Analysts changed outlook on top names: JP Morgan cut price target for Insulet, HC Wainwright slashed

EyePoint (EYPT) came out with a quarterly loss of $1.09 per share versus the Zacks Consensus Estimat

– Topline data from LUGANO pivotal Phase 3 wet AMD clinical trial expected in August 2026 –– – Topli

– COMO and CAPRI trials together rapidly enrolled over 480 participants in five months, demonstratin

EyePoint (EYPT) doesn't possess the right combination of the two key ingredients for a likely earnin

Wall Street analysts change outlook on top names. Check out analyst ratings page for upgrades, downg

WATERTOWN, Mass., July 16, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committ

Stifel analyst Annabel Samimy initiates coverage on EyePoint (NASDAQ:EYPT) with a Buy rating and

Globally renowned retina specialist and key opinion leader to provide strategic guidance across clin

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Unlike SpaceX, ADMA Biologics is already profitable and has a clear path to doubling over the near t

WATERTOWN, Mass., June 16, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committ

EyePoint, Inc. (EYPT) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transc

Eyepoint Pharmaceuticals NASDAQ: EYPT executives said the company remains on track to report top-lin

WATERTOWN, Mass., May 19, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committe

WATERTOWN, Mass., May 18, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committe

– LUGANO topline data on track for mid-2026, with LUCIA readout to follow shortly after –  – Continu

EyePoint is rated a clear BUY, with central-case DCF modeling indicating roughly 2x upside from curr

EyePoint, Inc. (EYPT) Q1 2026 Earnings Call Transcript

EyePoint (EYPT) came out with a quarterly loss of $0.99 per share versus the Zacks Consensus Estimat

WATERTOWN, Mass., May 06, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committe

WATERTOWN, Mass., April 29, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company commit

Eyepoint Pharmaceuticals, Inc. (NASDAQ: EYPT - Get Free Report) insider Ramiro Ribeiro sold 2,437 sh

WATERTOWN, Mass., April 16, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company commit

Summary:Top Wall Street analysts changed outlook on top names. Analyst ratings page shows all chang

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earning

Shares of Daktronics, Inc. (NASDAQ: DAKT) moved lower during Tuesday’s session following weak quarte

Shares of U Power Limited (NASDAQ: UCAR) shares moved lower during Monday’s session after the compa

U.S. stocks traded lower this morning, with the Nasdaq Composite falling over 100 points on Monday.

EYPT: 416% | EyePoint Pharmaceuticals Announces Positive Topline Data from the Phase 2 DAVIO 2 Trial

Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1

Companies Reporting Before The Bell • Vanguard Extended Duration Treasury ETF (NYSE:EDV) is estimat

Gainers Aclarion, Inc. (NASDAQ: ACON) shares surged 152% to $1.85 amid the publication of durabil

Companies Reporting Before The Bell • argenx (NASDAQ:ARGX) is expected to report quarterly loss at

  On Thursday, 241 companies hit new 52-week lows.

  OnThursday, 137 stocks made new 52-week lows.

Companies Reporting Before The Bell • Nomura Holdings (NYSE:NMR) is likely to report earnings for i

  During Wednesday's trading, 517 companies set new 52-week lows.

  During Monday's trading, 528 companies set new 52-week lows.